but so i was president of lilly usa, which is half of the global company. eli lilly. and it was not at that time the smashing global success that it is today. and whenever i left and you know, you're becoming secretary, you can't hold on to lilly stock when you're the secretary of hhs. i think i got rid of everything at $62 a share last time i checked, lilly is at $950 a share. so if i had just gone hunting and fishing for the last seven years, life would have been really good. but you know what? and i should have mentioned this. it's great that i really appreciate getting this award, but this award is not for me. it's for the whole team. that was operation warp speed with secretary esper and the whole defense department team and all the people at hhs and the people from the private sector who we leveraged who came in, including people like moncef slaoui. he was the head of global r&d at gsk, and he came in to be our oppenheimer, our scientific director, to do that. he he had been on the board of a little company called moderna, and he had to walk away from that and g

i think lilly's ahead. i think lilly has an oral pill. think that they have great visibility in terms of their manufacturing. and i thought that zepbound was doing well. i was wrong on all three. >> i keep trying to draw you back into this discussion on rfk jr., who's no fan of obesity drugs, no fan of vaccines, no fan of fluorination of drinking water -- >> i think the sterling character in "dr. strangelove" would be running the fda. >> bodily fluids. >> he was at school with me, and that's terrific. that's all i have to say. >> no. >> i didn't vote for him. >> at this point -- >> fluoride? we're back on fluoride? >> what job would he have in the administration? >> tsar. czar of drugs. >> by the way, no fluoride. >> how about measles? where are we on measles? is he pro-measles? one kid had measles in class, and the next day, everybody had measled. where is he on that? >> i was joking over the weekend, time to go long henry schein. >> yes. that's very good. remember your buddy used to run stanley bergman, your pal. >> my pal? no. my grand

it was why she switched to monjaro a drug similar to ozempic that's made by eli lilly. but now she's at risk of losing that as well. >> i think it's utterly ridiculous. >> and last one, it's been extremely hard. at least ten patients a day cannot get these medications. >> here's the problem private coverage varies from company to company, and even medicare can vary from state to state making it all very confusing and hard to navigate and a lot of this disproportionately affects the black community. you see, black people are more likely than white people to have diabetes or obesity but they're also about four times less likely than white people to get a prescription for these medications. >> i'm angry at the system. i think anyone who wants the meds should be able to have access to the meds but there's another reason that so many people all over the world were unable to access these drugs. >> you see, when they were first introduced, there was actually little fanfare. but starting in 2021, celebrities influencers, they all began talking and tweeting and posting about the

that's made by eli lilly. but now she's at risk of losing that as well. >> i think it's utterly ridiculous. >> and list one. it's been extremely hard. at least ten patients a day cannot get these medications. >> here's the problem private coverage varies from company to company and even medicare can vary from state to state, making it all very confusing and hard to navigate and a lot of this disproportionately affects the black community. you see black people are more likely than white people to have diabetes or obesity but a less likely than white people to get a prescription for these medications. >> i'm angry at the system. i think anyone who wants the meds should be able to have access to the meds. >> but there's another reason that so many people all over the world were unable to access these drugs. you see, when they were first introduced, there was actually little fanfare. but starting in 2021, celebrities a tech mogul, social media influencers, they all began talking and tweeting and posting about thes

beyer >> i don't i don't care lilly is down 20% from the peak.ty to get back in. i sold lilly earlier this year because i didn't understand how the price cuts might affect things going forward and i think wall street has it wrong. everybody is concerned about how men scripts they are writing we are in the first inning of a long game. it's not about just weight loss. it's about alzheimer's, about addiction, and it's that lilly has an oral thing that they are working on for glp-1 drugs it's where the money is. does merck and pfizer have a plan they are dead in the water i don't want to do novo. lilly is the on pharmaceutical. >> we asked you for defense names. you chose aerospace player trans dine those shares down 7% this week why can you buy it here? >> my gosh, i love this company. they had earnings that came out, people were concerned about decelerating this or that. got hit, 6, 7% it's back. i love this company. it's a mini berkshire. in defense only thing i care about is arrow smas. we have to get hypersonic products, uavs that is the future

i would be more wary of owning lilly or novo on that, than i would with bio tech. calling for, you know, it's tough to make a bearish case on bio tech. i'd be more leery on pharma. >> yeah, jared, thank you for making sense of it. some people out there were a bit confused. appreciate it. >>> coming up, golden gains or hi-ho silver? what the chart master sees in the technical of the precious metal trade. a dream into a reality. it's waiting for you. mere minutes away. the future is nothing but power and it's all yours. the all new godaddy airo. get your business online in minutes with the power of ai. - [narrator] we just signed the lease on our third shop. get your business online my assistant went to customink.com to get new uniforms with all the locations. he found great products, uploaded new art, and had boxes sent to all the shops. custom ink makes it so easy. get started today at customink.com. let's go boys. the way that i approach work, post fatherhood, has really been trying to understand the generation that we're building devices for. here in the comcast

a spokesperson for lilly which produces mounjaro in the uk said: patient safety is lilly's top priorityent of the benefits and risks of the medicine. a spokesperson for the mhra said this. our sincere sympathies are with the family of the individual concerned. no medicine would be approved unless it met our expected standards of safety, quality and effectiveness. tirzepatide is one of a group weight loss drugs known as glp—i receptors. they work by making the patient feel fuller for longer. these drugs have passed all the clinical trials needed to be approved for use in the uk and have been cautiously welcomed by those working to tackle obesity. on the basis of single cases, it is difficult to establish cause and effect, it really is. but in the vast majority of major outcomes, very common outcomes, trials are very robust in trying to establish safety, that the drugs generally have substantial benefits that outweigh the risks. tirzepatide became the subject of national debate recently by the health secretary announced plans to roll it out to unemployed people to help them back into work

the eli lilly pen for example, has 14 unique parts each one of them has to be molded, snapped together, and then quality tested all we know is essentially the more we make, the more gets used i've made my way to a pharmacy outside of new york city, here on long island, it's probably going to look a little different than any pharmacy that you've seen before. this is called a compounding pharmacy, and one of the goals here is to provide alternatives for medications that are currently in shortage. let's take a look at how they do it compounding medications for decades and lately his business has been booming lab where it's all done this is what a product of semaglutide or semaglutide would look like. so it comes packaged on ice. it comes from an fda approved wholesaler with a certificate of analysis. this is what it is so it's literally one gram of powder that powder is then diluted sterilized, packaged and quality tested. now that's not the actual fda approved product, but it is thought to have a similar effect. so this is what comes in as the active pharmaceutical ingredient. and this i

president biden is proposing medicare and medicaid coverage of the obesity drugs so you can see eli lilly up near session highs the better part of 6%. let's take a look at the shares of rocket lab up for the fourth day in a row. up 30%. today up a healthy and 9.4 percent after they completed two lunches in less than 24 hours. you are mentioning the tariffs. they may not be affecting the broader market on the surface level but the automakers who will be a sexually sensitive to tariffs, the 25% tariff mexico. ford, and gm down. dm has the largest exposure any terms of cars produced from mexico. down eight point sent -- don't 8%. might be worse than the day of june in 2022. the stock keeps going to session lows. ford come about 400,000. anyway you look at this, there is likely to be some pain. baird saying up to one million vehicles, the vehicle sales of one million vehicles could be cut because of these upcoming tariffs. fantastic round up. the word of the day is clearly tariffs. president-elect donald trump threatening to slap 25% tariffs on all goods from mexico and canada. . that is why

novo nordisk and eli lilly said there is still plenty of demand here. he have one will be watching closely. these earnings are similar to nvidia where people want to see exactly how they can compare to the estimates. i think it's still early on if you listen to dave rickts at eli lilly, he says we're in the first inning. >> he sounds like dan ives. the after party, a whole thing. very interesting stuff. anjelica, thank you for joining us. >> thank you. rlidcoming up on "wodwe exchange," cnbc disruptor canva making big moves ahead of the expected ipo. we have the details coming up after this break. stay with us. (♪♪) at enterprise mobility, our experts always see another road. because when there's no limit to how far mobility can go, there's no limit to how far businesses can go. (♪♪) >>> welcome back to "worldwide exchange." time for the big money movers. we're going to start things off with coffee futures. you are probably starting with coffee. futures up 50% this year and trading at the highest level since 2011. with concerns of dry weather and defore

we have had a lot of news in the glp-1 space so to speak involving names like eli lilly. the next guest is bullish despite stock bowling. this is in reaction to mid- stage trial results for the experimental obesity drug. we have the leading biotech analyst who has a rating on the stock. price target 3.75. nice to have you here. you said in order report yesterday that you continue to see a highly differentiated asset with this dragon remain confident in the outlook for it. why do you differ from what was not a decidedly positive reaction from the market? >> i think what happened yesterday was people really couldn't understand the differentiation versus eli lilly and the drugs. they want more details as it relates to the tolerability profile of the drug. the reason we think it is differentiated is, one, you have efficacy that looks in- line with eli lilly about a 20% weight loss after one year. but it looks to be deepening over time. it looks like you could have more weight loss past 52 weeks. and in addition, it is the one this a month or less frequent injection and that d

you might have taken it, lillie. it was her first home game after returning from russia and i saw her and we went right to each other, got a big hug and whisper ed being grateful that brittney's home and someone snapped that photo and i look at it often because i miss her. there are things that are unforgettable about her and the one that sticks in my mind the most is, tell me if you've gotten these, too. i would have notes on my phone if i had to open it up, if i put my phone down for an hour or went to sleep, i'd wake up and road this about all these notes, please call me. i can tell you i miss her. she was a great friend and advocate for what we do and i can tell you this much. i know where she is right now. she heard the phrase, well done my good and faithful servant and if they issue iphones in heaven, i know if i get up there and turn that thing on, it will go, please call me, please call me, please call me. i'm going to miss her but i know she's where she needs to be and i know i'll see her one day and erica,

>> i think you have to look at lilly/novo first as big winners that come in, i think on two things.people away in order for the stocks to go up. they did not do that and now we have this uncertainty politically. the demand curve is still amazing and they'll close to market or on market with assets that pharma may be interested in at some point the m&a trade is very -- >> alive and well and will probably pick up and a lot of investors are keen to it. you can go down the cap structure probably into next year. >> viking therapeutics, what you just described? since the election a pretty difficult go. do you think things have changed? >> rfk and others might do in terms of preventative medicine and some of the rhetoric along the lines of not so pro this space. the issue with viking is simple. the only way they can be successful is if they are too difficult, too expensive to run alone, unless you get the headline, it's going to be a difficult run. that being said, there is going to be data the next year or so that could reinvigorate it. >> i like the comment in one of your notes about all

on the capacity constraint their blockbuster drug was in shortage, so that's -- and you're seeing lillyle sailers they're saying that's going to resolve that issue, but they have massive markets there's still a lot in front of lilly. >>> just last buy is my favorite it is peloton. the shares are up 30% this week. granted they had the much stronger than expected earnings, but they might be coming to costco, but i would buy the costco side of that pair of a trade. >> i used to love to hate peloton, and one of the reasons is because it was so overvalued, really mired in the manufacturing side of what they did, and had a multiple that didn't make sense. they refocused with mccarthy and now the new announcement with peter stern, that's a focus shift to the app experience. i think they'll back away from the manufacturing side of what they do, and focusing on the subscription sales that does deserve a multiple >> you have an opportunity today, down 14%, your bail is snap they beat earnings, big deal their user base is unlikely to grow, and that was our mystery chart today. >> exactly if the us

a spokesperson for lilly which produces mounjaro in the uk said: patient safety is lilly's top prioritys. our sincere sympathies are with the family of the individual concerned. no medicine would be approved unless it met our expected standards of safety, quality and effectiveness. tirzepatide is one of a group weight loss drugs known as glp—1 receptors. they work by making the patient feel fuller for longer. these drugs have passed all the clinical trials needed to be approved for use in the uk and have been cautiously welcomed by those working to tackle obesity. on the basis of single cases, it is difficult to establish cause and effect, it really is. but in the vast majority of major outcomes, very common outcomes, trials are very robust in trying to establish safety, that the drugs generally have substantial benefits that outweigh the risks. tirzepatide became the subject of national debate recently when the health secretary announced plans to roll it out to unemployed people to help them back into work. i think anything that is backed by the government you would trust. i would urge

in terms of the xlv, li lilly, the top holding, these vaccine companies are in trouble it's not coincident that mow determine that made a 52-week low, pfizer hasn't traded well, glaxosmithkline and the xlv is under significant pressure unh is still at the top of the pile what happens with some of them i'm not trying to be an alarmist but if you own xlv, you have to re-examine your thesis because it might change dramatically. >> this is where it's important to know not to fall into the short-term headlines like the trump trade where the initial reaction is, there's going to be less regulation, which is good for mergers and acquisitions and good for the health care space and some of your pharmaceutical companies because same headlines with new administration, it's a negative for that space. this is where you should not be trading on the political headlines as much as as it is underlying value of these companies. >> we've seen this sector under some pressure because there are some perceptions about what this trade was like a month ago and then you have -- frankly, a couple of companies that h

>> eli lilly. >> lilly was down sharply yesterday. >> lilly right now has lost the mojo.chnical term. no mojo, carl. >> it's in a bear market. yeah. >> gentyes, it's one of the lon bears in an amazing bull market, but they have to come out and re -- they have to reaffirm what they said, and they need a new use to be able to demonstrate why it should be paid for by the health maintenance. i'm nominating that one as the worst call of the year, the lilly call. the single worst conference call. david ricks. >> largest market cap company in europe, i believe. >> i told you europe's coming back. >> every day. >> glp-1s are helping that. high 5%. their diabetes and obesity care and danish croner was up 25%, mainly driven by glp-1, sales growth of 25% again. obesity care growing by 44% as well. >> yeah. >> for novo. and then the foundation -- so many interesting parts of this story because the foundation owns so much of it. they're funding the largest super computer in the world. i don't know if you guys have seen that. >> jensen huang spent a lot of time in denmark, lot of time

eli lilly.t at that time the smashing global success that it is today. i left, you'll becoming sector you can hold onto lilly stock when you're the secretary of hhs. i think a get rid of everything at $62 a share. last time i i checked, lily it $950 a share. so if i just gone hunting and fishing for the less seven years life would've been really good. but you know what? i should've mentioned this. it's great and really prescient getting this award but this award is not for me. it's for the whole team that was operation warp speed with secretary esper and the whole defense department team and all the people at hhs and people from the private sector who came in a clue to people like the head of global r&d at dsk and he came to beer scientific director. to do that he'd been on the board of a little company called moderna and you to walk away from that and give that up. that meant probably sacrifice a billion dollars to serve his country. i think with paying one dollar. and get nothing but abuse. no

you have lilly getting the big money that they need, so then the insurance companies will all followably worth -- my travel trust owns it. we bought some yesterday. it's probably worth 50. but people are skittish. >> so are the hershey's and smuckers a natural short here. >> smucker went out of their way to talk about how the -- they saw no incident of glp-1 pressure when it comes to hostess. it went out of the way and said it. and -- versus uncrustbles which is what they're talking about. they had to build a new factory because the denver broncos can't eat enough of them. bo nix, who knew. >> i was familiar but during the break i was informed of the consumption habits of nfl players of uncrustbles. >> number one food. >> quite a significant audience for them. >> i thought it was campbell's suit. >> and donovan. >> exactly. and donovan's mom number five. yeah. >> goes back to deep track. >> it does. but it's in crustbles. >> you're a few gatto. >> you're a fugatto. >> wondering what that is about this video that nvidia has released about turning text into sound. cramer's mad dash and

the fact that you bought lilly this week on that pull back that it had, talk more about that. >> yeah. i mean, it's not cheap, scott, so i'll give you that, but it is the number one franchise in one of the hottest places to be in terms of weight loss and diabetes. you're talking about between the two, about a $500 billion total addressable market by the end of the decade, and i'm probably low by a factor of two or three times. this is, as i mentioned, the number one player, and i think that they just delivered 42% total revenue growth in the quarter. if you want to x out the diabetes and weight loss drugs they still grew their legacy businesses 17% in revenues. find me any pharmaceutical company that is growing at that level with the best in breed company management team, with prescription trends sequentially in weight loss and also diabetes up 25%. 25% sequentially. and so this is not a demand problem, this is a supply problem. i would go back to the market as a whole is -- you're right, it's not cheap, but there are themes. animal health is one. financials are another. and housing i

the board in the art market this week. >> in terms of the art market, you know, you mentioned water lillynism first erupted, a lot of people said why would you spend money on it? you can't tell what it is. beauty is in the eye of the beholder. if i were to duct tape a banana to my wall, would it have value? >> reporter: it would have maybe value to you. what makes this valuable is that certificate of authenticity. it's a bit like an nft. it's like sotheby's where it is the first lot in the auction where they accepted crypto. much like an nft, it is the certificate of authenticity saying this is a an. this gives you the right to say this is an original piece. there are three pieces. without that certificate, contessa, it's not the same banana. >> is there a secondary market? can he sell the same roll of duct tape? >> reporter: he'll set the certificate. whoever bought this in 2019, everyone said he was crazy. he flipped it for 6 million. that is 25 times the s&p over that same period. >> robert, i appreciate it. >>> coming up, why my next guest is trimming his position in nvidia for greene

lilly up 1.6%, although pfizer down again. i am sure you guys saw they have a new head of r&d at pfizer. they are still dealing with the challenge from starboard and zwref smith, significant activist in their shares. there is a -- take a look at lilly. there is pfizer. we talk about pfizer in terms of the disappointing performance of that company over a long period of time. and certainly since the end of the pandemic as well. >> did you catch on the walmart call that they talked about how the gop -- actually hurt their gross margins because there is so much business? that's lilly. and what's also wegovy -- >> wait. i am not following. >> on the walmart call -- >> yes. >> they said in the pharmaceutical side it was good, but they had some gross margin pressure, gop-1. they are selling so much. this stock came down from the 900s. we put out a bulletin yesterday when it was 710, buy it. if you don't own lilly, buy it. it's a juggernaut. when they mentioned on the walmart call, oh, my god, are the grocery sales down because of it?

weight. >> astrazeneca has the pill back in early-stage trial, that's what i want is the pill. >> eli lilly so two people potentially. >> marriott. >> return to the annual profit forecast they say travel demand in u.s. and china and the stock is down 2%. >> sherwin-williams. >> they will joined the dow jones industrial friday morning they replace the dow chemical company up for another percent. >> they are big enough to get into the dow industrial. >> they sell premium priced paint spinnaker take your word for it, today jd vance and tim walz will make one last pitch to voters in wisconsin, mike tobin is in la crosse. what can we expect from the vp candidates. >> it is all done as far as persuasion from the vp candidates and so many of this arrogance trying to pump up the base. jd vance is expected to speak at the la crosse center any minute, the candidates of presidential candidates have made their final appearances in wisconsin the vice presidential letter getting wisconsin soil on their shoes and what we saw on that we can with the parade of surrogates doing what we talked about trying to

. >> 14 lilly williams. one for joseph e kenny. one for david [ inaudible ] and one for arnold g davis. 14 --, one for john mccormick. one for suzanne collins. one for leon h --, one for terry l peterson. one for ray gorman, and yes on the constitutional amendment question. one for donald trump and jd vance. one for kelly this hour. one for lilly king williams and one for joseph e kenny. one for -- >> all right. we will dip back out of this as they read the complete ballots of the people who voted a moment ago. let's go back to what will happen down ballot. an enormous amount of money has been put not just in this presidential race but an unprecedented amount of money in this senate and congressional campaign. jon tester said if you were to win, the first thing he wants to address is how much money has gone into these campaigns. did you ever think when you are a member of congress, the numbers that we are talking about now are of another stratosphere. that is in part because the richest people in this country, the richest people in

. >> we are getting closer what you see eli lilly and the other competitors to the downside because bikingthis i don't get it wrong 100 milligrams dose of biking patient lost eight-point to percent of their body fat after 28 days that is 6% more than those taking a placebo so you're losing weight in your losing a lot of it. >> i wanted. >> to it the old-fashioned way stop eating the cake captain e diastolic. >> what are you my mother. >> warren buffett eli lilly, apple down a little couple of dollars, warren buffett sold more of his stake in apple. how much did he sell and how much does he have left. >> he sold 25% of his stake last quarter and for the year he sold 60% of his stake that was originally making you feel nervous but fear not he still owns $70 billion of apple and its largest holding in his down from 173 billion of which he had at the end of last year we don't know why some pretax invocation that people eager to know why because he's the oracle of omaha and he's not saying. thank you, we are now five minutes into the trading session on a monday morning the day before the electi

people who come to cricket stay with cricket, like lilly.me to life without hidden fees. welcome to cricket nation. “smile, you're on cricket!” the best ai assistant isn't one that knows the whole world. it's one that knows your world. a custom assistant, built on watsonx with ibm's granite models, can leverage your trusted data, be easily trained on your workflows and integrate with your apps. it can be tuned to do just what you need. because the more ai knows about your world the more it can help you do. ibm. let's create. ♪ ♪ ♪ where have you been? north pole. ♪ hey, there, watch this! —boom! —wow! ho! ho! ho! ♪ ♪ what's in your wallet? ♪ ♪ energetic music playing ♪ ♪ ♪ can you save water using a less than full dishwasher? we do it every night... do it with cascade platinum plus. one load of dishes in the sink uses 24 gallons of water while a dishwasher uses less than 4 per cycle. so do it with cascade... the surprising way to save water. some people just know they could save hundreds on car insurance by checking allstate first. okay, let

he did not disfavor a competing weight loss product, eli lilly's that bound, even as it lost as a list price percent lower than wegovy. here is what health group optimum except, no, assuming the net price remains the same or lower, lowering the list price would not lead to less favored or miller by rx. particularly for high-end drugs like to pick and wegovy. to be clear, lower list prices and lower net prices support access. cbs healthcare mark said, something similar. the simple answer is, no. in fact, we can point to recent history as a proof point. when novo nordisk drastically reduced the price of their insulin, in 2023, it did not result in a less favorable formulary placement with caremark. they were also asked if ozempic and wegovy were available for $100 or less per month, what impact do you expect it would have on coverage and access? cigna express that, if novo nordisk lowered the price for plans sponsored to $100 or less for patients per month, we would expect the vast majority of our clients to expand coverage in excess to these products for diabetes and weight loss, assumi

you know, things in general -- >> i wanted to show the monet water lilly because that is art and those, however, say the person who bought this for $120,000 in 2019, everyone said that guy is an idiot. listen, that guy is an idiot. his return is five times what the s&p is over the same period -- sorry, and twice as good as nvidia's stock over the same period. we could say it's crazy, but maybe in five years it will resell for 30. who knows? >> it's because of this guy, maurizio cattelan, that makes it -- if i did it, it wouldn't be worth that. >> i would consider very valuable, tyler, if you did it. but maybe you could try with a tomato or apple or mango. >> do people in the art world think this is a sign of froth? you know the bitcoin money. you mentioned the nft -- >> in my newsletter, my parents are artists. i grew up in the art world. i find this absurd and outrageous. i interviewed for my newsletter today, which people can get, three art experts on what they think of the banana. and they all think it's genius. >> well, because it's conviction. i am so sick of iconic. how about bea

stuart: eli lilly?auren: rival novo nordisk said ozempic sales in the quarter missed expectations, echoing what eli lilly said last week. investors may think this weight loss drug market is overestimated, and just to point out the power of rfk jr.. he wants to make america healthy again, and interpretation could be well go on a diet and exercise, stuary varney. don't take a weight loss pill or injection. stuart: you have not forgotten that have you? >> no. stuart: i'll get the pill if it comes my way. i would do that. thank you. coming up some people in the media want to blame harris' loss on sexism and racism. we have leo terrell to respond to that. donald trump says these winners a victory for common sense. >> it was a historic realignment, uniting citizens of all backgrounds, around a common core of common sense. together, we're going to unlock america's glorious destination. stuart: look whose about to arrive on this set. the man who is constantly on television. his name is charlie hurt. it's great

p p patients taking some weight loss drugs have filed lawsuits against eli lilly.ay they were not adeq adequately informed of the use of the items and are developing health problems >>> consumers accused walgreen's for fraudulently overcharging customers while members of a savings club paid less without insurance. the company has ended the program. >>> amazon is roll oging out x- recaps. it is created down to the exact minute you last watch and prevents spoilers. >>> if it you need a ride to the polls, we've got election-day deals. lyft and uber are offering a 50% discount up to $10 or can you take an e scooter or ebike using the promo code vote 2024. >>> jersey worn by michael jordan was sold by sotheby's for $4.68 million, making it the fourth most expensive nba jersey of all time. of all time. ♪ like a relentless weed, moderate to severe ulcerative colitis symptoms can keep coming back. start to break away from uc with tremfya... with rapid relief at 4 weeks. tremfya blocks a key source of inflammation. at one year, many people experienced remission... and some

kline and also fears he doesn't like the obesity drugs that weighed on the makers of these like eli lilly and novo nordisk but some say the sectors is over sold with recent upgrades by the recent drugmaker biontech. >> we've got stocks like pfizer, merck, and j & j actually down on the year and there could be opportunities there. i'd point to pfizer which is near 52 week low around 25 with about a 7% dividend yield the stock which looks pretty safe. i'd also highlight covid vaccine maker moderna which is under 40 right now down about 60% with almost half its market cap in cash. >> 7% dividend sounds pretty nice. one of the few bright spots has been humana since the election, because of the idea that the medicare rules might change, that would help in its favor. >> that's right there's some talks a republican administration will be more favorable to medicare advantage which is of course the privately-run alternative to traditional medicare and that would benefit humana which is a pure medicare advantage play and they might benefit from increased government payment rates next year. >> which

i thi as lilly saidit didn't matter iwere in her congreional disict. you cod be in from mot, north dakota, spokane, washgton, you needed lp d you were being held foign country. she s all . d i spent hourshe pho and it wasever aurden because actuly ploing anschemi together about how to get stuff done. by the way, i'm not allowed to take those phone calls. so if there's anyone here from the department of state, chatham use that stays in your. but we worked hard on this and there was a after i ve her a brief and she was trying to bring peopleome from afghanistan, mali, china, venezuela, iran and at the end oft, i just sat back. i said, congrewoman, i got to tell you, i'm alexandria, virginia. and if i'm ever taken by a foreign country or a terrorist group, i'd like you to advate on my behalf. you know, it's she said, roger, i'll do you one better if you're ever taken the russians, i'll actuallyake you an honorary member of myistrict. and i'm going to bring you home. look one of my most tasured things that i've had in this job for four years is a photo tha

lilly is 21. she was at a club when she was spiked with a needle.n after, she reported it to the police. i felt a sharp scratch on my arm, and it was so quick i look to my right. there was a massive group of people around. it could have been any one of them. a headache started. i was very nauseous, very tired, dizzy. just general weakness, like that fatigue feeling. according to the most recent figures, there have been nearly 7,000 reports of spiking in drinks, and almost 1,000 with a needle in england and wales. we will be training thousands, 10,000 bar staff and people who work in the night—time economy and tens of thousands of door supervisors, bouncers, in the night—time economy, to look at how they can prevent this sort of perpetrator behaviour, spot it. ministers admit that the legislation might not make much difference, but they believe that the proposed plans will make detecting the crime easier, potentially giving people more confidence to drink in places like this. hannah was at a bar in cornwall when her drink was spiked. i don't even lik

. >> that's lilly there looking at the camera. >> reporter: until you learn what they're churning oute? the butter made here at animal farm creamery in shoreham, vermont can't be found in a grocery store. it's sold almost exclusively to fine dining restaurants around the country. from per se in new york to the inn at little washington in virginia, it's widely considered the cream of the crop. >> i actually have heard from people who have eaten it, and they say it's changed them. and it's great to hear that. i'm not quite sure how. >> don't give away our secret. >> reporter: for hillary hague and her husband ben, making butter is a family affair. they're the second owners of the business founded in or well, vermont. the creamery's name "animal farm" winks at the 1945 george orwell fable. how would you describe this butter to someone who has never tasted it before? >> well, it has this very light mouth feel, and then it has a very sweet taste to it too. it's an experience that involves aroma and texture and flavor. >> reporter: so this is where it all happens, in this little room? >> ye

lilly is 21. she was at a club when she was spiked with a needle. sharp scratch in my arm, and it was so quick. i looked to my right. there was a massive group of people around. it could have been any one of them. a headache started. i was very nauseous, very tired, dizzy. just general weakness, like that fatigue feeling. according to the most recent figures, there have been nearly 7,000 reports of spiking in drinks and almost 1,000 with a needle in england and wales. ministers admit that the legislation might not make much difference, but they believe that the proposed plans will make detecting the crime easier, potentially giving people more confidence to drink in places like this. we will be training thousands, 10,000 bar staff and people who work in the night—time economy, and tens of thousands of door supervisors, bouncers, in the night—time economy, to look at how they can prevent the sort of perpetrator behaviour, spot it. there are a number of measures we are setting up. the prime minister met police and hospitality staff this morning to wor

lilly, tell us about this experience from appearing on stage with the former president, what was thatid not know we would be invited on stage until the minute we got there. i got the call and i took the call and said, i will do this, i am passionate about this cause. i had two hours to write a small speech to get the message across men do not belong in women's sports. president trump allowed us to do that, something very, very cool. >> carley: so cool under pressure, i guess as a college athlete, have you to be. tell us the back story. we heard from the president, there was a transgender swimmer who competed on the men's team and wanted to gin the women's team and it did not happen. how did you feel when this was trans pyring and why you decided to fight back. >> we felt hopeless, we were put in a position we should not have been put in. we were told they were putting this one athlete over the 17 of us and we had to deal with it. we didn't think it was fair, we saw the unfairness and thought n ncaa and our school would support us and they did not. we reached out to -- and riley gaines

i'm talking about eli lilly. >> this stock is as hated now as it was loved not that long ago.ught some today. we were restricted. i think enough is enough on the selling. let's go to reed in maryland. reed? >> hi, cramer. shout out to ethan cronin. the stock i was interested in was coin base. >> coin base is what i call an upstock. it's just an upstock. palantir is an upstock. coin base is an upstock. there are buyers every time they pull back and there probably will be to your end. point base is a winner. deane in texas. >> booyah from the great state of texas. ies holdings. their numbers are out next month. >> this is a terrific infrastructure play. we know it. and one of the things i didn't know about is it's jeff gendel's company. he's really fabulous. he gets everything. this is a just fantastic stock! when we did a profile about it, we were not offusive enough. ford? >> what's your thoughts on semtec, smtc? and then possibly if you could tell me about american super conductor? >> i don't like it. it's always a bridesmaid, never a bride. it's a traditional semiconductor c

take a look at the vaccinemakers, moderna, eli lilly, pfizer, ucsc of red, they are down big after donaldmp nominated rfk junior as hhs secretary, skeptic of vaccine, all the vaccine makers down as a result. stuart: amazon facing questions from congress about their growing relationship with tiktok. what exactly are lawmakers looking for in tiktok? ashley: amazon has a shopping partnership with tiktok that allows users to purchase products from amazon without leaving the chinese owned social media apps was representatives from amazon recently met with the house china committee whose members believe the arrangement could very well be dangerous and unwise given the national security threat the apps could pose. neither committee members nor amazon commented on the meeting. and if it does not do that with bike dance but it is unclear what will happen next. donald trump promising on the campaign trail he would, quote, save tiktok. stuart: donald trump is considering halting the ban on tiktok. what will trump do, do we know? >> tiktok has unlikely hope with the president-elect, we are two months

when they are hearing from be it pfizer or eli lilly , because they are providing support, that is how washington works . >> it could be one of the last issue standing that can cut across party lines based on if you have a medical device manufacturing in your state you may not align exactly the way they might expect. >> donald trump has a trifecta of government control this time around even with the majority his cabinet will be a true test of loyalty plus the richest man in the world's impact on trump's transition . plus, new developments on the house ethics probe into matt gaetz and a curious cancellation for an event that was scheduled for today. >> matt gaetz has chosen to resign from the house but he cannot choose to conceal that information. >> it is my understanding it is not supposed to go public . if it is not supposed to under the rules it should not go public. >>> do you think matt gaetz can get through ? >> i do not know the answer to that just yet. as you point out there are some skeptics but he deserves the process. >> very measured. coming senate majority leader john soon

shares of eli lilly, down 25% from the record high hit in august. >>> tesla riding high today, up nearly-driving rules. we have all of the details on this one. phil? >> reporter: it comes down to who will be the transportation secretary. the indication according to a report from bloomberg, the authority for secretary will be the advancement of autonomous technology. tesla will benefit from that. that is why tesla got a hike today. not a surprise. everyone known that elon musk will likely be pushing the trump administration to advance autonomous vehicle advancement and ease oversight. that in theory should speedup the develop. of tesla robotaxis. the reason the shares are up since election day is because of the anticipation of what this market could turn out to be. estimates are all over the place. arc investments, or it estimates that the market could be $11 trillion. a lot of other analysts think it is inflated and it is lower. regardless, a huge potential market. you have to keep a couple things in mind. first of all, tesla is not anywhere close to autonomous driving yet. right now it

nrg, consolation energy, eli lilly, western digital and they're on the list and up big time.new warning from the nypd, venezuelan gangs are trying to recruit children. we'll tell you how they infiltrate migrant shelters. alec baldwin says americans are uninformed. >> americans are very uninformed about reality and what's really going on. with climate change, ukraine. stuart: why does he go on foreign soil to talk down to americans? the new york post jon levine takes that on. jon is next. ♪ when you're in the military you're really close with your brothers and your sisters that are in the military with you. and when you get out of the military, you kind of lose that until you find a new family. we can talk about our struggles and the things that we did overseas and not everybody can do that. adam! how's it going, brother? we live pretty close to each other. so he's always coming over. when i go to jack's house, we watch a lot of football, hang out. we go outside the friendship has kind of grown into a family i was overseas on a deployment. i got separated from my marines and i

it's fair to ask what's the difference between a banana for $6 million and monet's water lillys for $65nana won't stand the test for a week. having money, how you use it on a banana or on a $200 million yacht says a lot about who you are. the $6 million could have done good. instead, justin sun in pursuit of art or publicity or both went bananas. that's an egregious almost tragic waste. what do you say? >> i think people have options and looks like that was a decision he made and could have been used for a lot of better purposes too. >> it's a question of right and wrong or right and not right to me. >> we're also in a world of social media and people like to get attention to do things that bring them attention and that's the 15 minutes of fame that he's probably going to have. >> 15 minutes of fame and buy a lot of bananas. >> you to give him a couple minutes of fame. >> a little fame. >> you know how i feel about it. very much -- >> do tell. >> you know, i would be more excited if there were some really great art that we could all be excited about and doing well and robert tried to br

the press turning out to be, yes, weak-kneed and lilly livered as you might fear in some quarters, buto defiant and professional and aggressive and creative in other quarters. the american free press thus far, for example, has been doing a great job detailing the astonishing conflicts of interest and self-dealing and deep incompetence and lack of qualification, the salacious and allegedly criminal past dealings of the freak show lineup that trump announced as nominees for high office. we will get to some of those this hour. so his intentions for what he wants to install and what he wants to do and how he want to consolidate power so the american government is essentially just the will of one man, those are just his intentions and it's worth being clear that those are his intentions. it's reporting on it t following it, being very clear-eyed about the fact that's what he is trying to do. just because those are his intentions doesn't mean those things are an inescapable fate for us as a country. politics still works. gravity still applies. the rules of nature still work. right? each of t

{lilli was something to do with football, and ijust... football, and i 'ust...otball _ football, and ijust... oh i see. a football related - football, and ijust... oh i i see. a football related thing football, and ijust... oh i - see. a football related thing i said it to one of the staff, they mentioned it and... the im act they mentioned it and... the impact of _ they mentioned it and... the impact of that _ they mentioned it and... the impact of that on _ they mentioned it and... the impact of that on your life must have been devastating the first three four _ must have been devastating tie: first three four year, the ptsd was came in, i wasn't getting help, being let down by the people who are meant to look after you. people who are meant to look afteryou. but people who are meant to look after you. but finally you have to start getting through things yourself. i am glad i am here to talks to you. i yourself. i am glad i am here to talks to you.— to talks to you. i am very grateful _ to talks to you. i am very grateful for _ to talks to you. i am very grate

both eli lilly and -- have first advantage in their business. the likely buy the drugs competing with them and one of those cases they have a better return on investment because they don't have to build out marketing structure and they already have that. particularly with this most recent correction, we like these companies. >> even with what may be a changing political calculus? you factor that in in the way you're thinking about these stocks at all? some are suggesting maybe the goalposts are moving as we speak as it relates to not only these kinds of stocks but the vaccine makers, et cetera. >> to us, it's always a great reminder these companies are run by smart management teams that can pivot as we have new policies come to fruition. you look at the long-term trends you find companies are trying to target to that the key thing they are creating great value over the next couple of decades. >> we will leave it there. ali, thank you steph, thank you professor, when you have your outlook for 2025, you give it to us first that is the deal. >> i w